Cardiovascular Renal Metabolic

Nicolas M Van Mieghem

Watch time: 9m 56s (3 videos)

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
EASD 25: Prespecified Analysis of CONFIDENCE

Rajiv Agarwal

Watch time: 7m 31s
ESC 25: The SEMA-VR CardioLink-15 Trial

Subodh Verma

Watch time: 4m 27s
Semaglutide Modulates Key Pathways to Resolve MASH, Proteomic Analysis Reveals

Radcliffe CVRM

Tirzepatide Benefits in HFpEF Consistent Across Obesity Levels, SUMMIT Analysis Shows

Radcliffe CVRM

New Multi-Ancestry Polygenic Score Improves BMI and Obesity Prediction Across the Lifespan

Radcliffe CVRM

Managing Obesity in HF: 2025 ACC Scientific Statement

Michelle Kittleson

Watch time: 8m 5s
ESC Congress 2025 Releases its Late-Breaking Scientific Programme

ESC Congress 2025 Scientific Programme

ADA 25: Final Results of the CATALYST Trial

Watch time: 13m 50s
ADA 25: Clinical Implications of STRIDE for Endocrinologists

Watch time: 9m 52s
ESC Congress 2025 Releases its Late-Breaking Scientific Programme

ESC Congress 2025 Scientific Programme

HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s

Nir Uriel

Watch time: 34m 39s (5 videos)

Jose Lopez, Tracy Makuvire, Jonathan D Davis, et al

Read time: 26m 29s

Fausto J Pinto, John Spertus, , et al

Gurushankar Govindarajan, James R Sowers, Craig S Stump

Keith C Ferdinand

ACC.24: The STEP HFpEF DM Trial

Mikhail Kosiborod

Watch time: 6m 41s

Debbie L Cohen, Raymond R Townsend

HFA 24: FINE-HEART: Design & Baseline Characteristics

Muthiah Vaduganathan

Watch time: 4m 40s

Andrew JS Coats, Stefan Anker

EASD 22: SURMOUNT-MMO: Tirepatide in Obese Type II Diabetes Patients

Steven E Nissen

Watch time: 7m 48s

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano, et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s
EP 87: Gut Microbiome and Heart Health: The 3 Compounds You Need to Know About with Dr Vuyisich

Ankur Kalra, Momchilo Vuyisich,

Listen time: 45m 50s

Media

Nicolas M Van Mieghem

Watch time: 9m 56s (3 videos)

Nir Uriel

Watch time: 34m 39s (5 videos)
HFSA 25: Sex-Specific Outcomes of Tirzepatide in Obesity-Related HFpEF

Barry Borlaug

Watch time: 7m 15s
ESC 25: The SEMA-VR CardioLink-15 Trial

Subodh Verma

Watch time: 4m 27s
EASD 25: Prespecified Analysis of CONFIDENCE

Rajiv Agarwal

Watch time: 7m 31s

Yassir Javaid, ,

Watch time: 1h 7m 32s (4 videos)

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum, et al

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
AOM 2024

Harold Bays, Naveed Sattar, Mikhail Kosiborod, et al

Managing Obesity in HF: 2025 ACC Scientific Statement

Michelle Kittleson

Watch time: 8m 5s
ADA 25: PATHWEIGH: Weight Management in Primary Care

Leigh Perreault

Watch time: 4m 46s
ADA 25: MariTide Treatment for Obesity in Patients with or without T2D

Harold Bays

Watch time: 6m 23s
ADA 25: Clinical Implications of STRIDE for Endocrinologists

Watch time: 9m 52s

Articles

SGLTi and GLP-1 in HF

Jose Lopez

,

Tracy Makuvire

,

Jonathan D Davis

,

Salvatore Carbone

,

Published:

13 May 2025

Citation:

US Cardiology Review 2025;19:e12.

DOI:

https://doi.org/10.15420/usc.2024.44
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1614
  • Downloads: Downloads 250
  • Read time: 26m 29s

HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick

,

Pratik Sandesara

,

Arshed A Quyyumi

,

Laurence S Sperling

,

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):49–53

DOI:

https://doi.org/10.15420/usc.2019.3.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1733
  • Downloads: Downloads 46
  • Citations: 10

Diabetic Cardiomyopathy: Five Major Questions with Simple Answers

Miguel Alejandro Rodriguez-Ramos

,

Published:

12 March 2019

Citation:

US Cardiology Review 2019;13(1):46–8

DOI:

https://doi.org/10.15420/usc.2018.18.2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 502
  • Downloads: Downloads 29

Diabetes Drugs and Cardiovascular Event Reduction: A Paradigm Shift

Erik M Kelly

,

Donald E Cutlip

,

Citation:

US Cardiology Review 2018;12(1):46–50.

DOI:

https://doi.org/10.15420/usc.2017:35:1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 215
  • Downloads: Downloads 10